GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HealthLynked Corp (OTCPK:HLYK) » Definitions » ROE %

HLYK (HealthLynked) ROE % : 0.00% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is HealthLynked ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. HealthLynked's annualized net income for the quarter that ended in Sep. 2024 was $-7.89 Mil. HealthLynked's average Total Stockholders Equity over the quarter that ended in Sep. 2024 was $-1.18 Mil. Therefore, HealthLynked's annualized ROE % for the quarter that ended in Sep. 2024 was N/A%.

The historical rank and industry rank for HealthLynked's ROE % or its related term are showing as below:

HLYK' s ROE % Range Over the Past 10 Years
Min: -13508.73   Med: -234.53   Max: -180.88
Current: -13508.73

During the past 8 years, HealthLynked's highest ROE % was -180.88%. The lowest was -13,508.73%. And the median was -234.53%.

HLYK's ROE % is ranked worse than
100% of 625 companies
in the Healthcare Providers & Services industry
Industry Median: 4.77 vs HLYK: -13508.73

HealthLynked ROE % Historical Data

The historical data trend for HealthLynked's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HealthLynked ROE % Chart

HealthLynked Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial - - -243.47 -234.53 -180.88

HealthLynked Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -44.69 -434.83 -1,082.26 - -

Competitive Comparison of HealthLynked's ROE %

For the Medical Care Facilities subindustry, HealthLynked's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HealthLynked's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthLynked's ROE % distribution charts can be found below:

* The bar in red indicates where HealthLynked's ROE % falls into.



HealthLynked ROE % Calculation

HealthLynked's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-1.012/( (0.314+0.805)/ 2 )
=-1.012/0.5595
=-180.88 %

HealthLynked's annualized ROE % for the quarter that ended in Sep. 2024 is calculated as

ROE %=Net Income (Q: Sep. 2024 )/( (Total Stockholders Equity (Q: Jun. 2024 )+Total Stockholders Equity (Q: Sep. 2024 ))/ count )
=-7.892/( (-0.425+-1.933)/ 2 )
=-7.892/-1.179
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2024) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.


HealthLynked  (OTCPK:HLYK) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=-7.892/-1.179
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-7.892 / 2.36)*(2.36 / 3.309)*(3.309 / -1.179)
=Net Margin %*Asset Turnover*Equity Multiplier
=-334.41 %*0.7132*N/A
=ROA %*Equity Multiplier
=-238.5 %*N/A
=N/A %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=-7.892/-1.179
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-7.892 / -7.892) * (-7.892 / -3.82) * (-3.82 / 2.36) * (2.36 / 3.309) * (3.309 / -1.179)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1 * 2.066 * -161.86 % * 0.7132 * N/A
=N/A %

Note: The net income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


HealthLynked ROE % Related Terms

Thank you for viewing the detailed overview of HealthLynked's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


HealthLynked Business Description

Traded in Other Exchanges
N/A
Address
1265 Creekside Parkway, Suite 302, Naples, FL, USA, 34108
HealthLynked Corp operates a cloud-based online personal medical information and records archiving system for patients and doctors to keep track of medical information via the Internet in a cloud-based system. It operates in three segments: Health Services, Digital Healthcare, and Medical Distribution. The majority of its revenue is generated from the Health Services segment, which is into operations of Naples Women's Center, Naples Center for Functional Medicine, and Bridging the Gap Physical Therapy.
Executives
Robert P Gasparini director 12701 COMMONWEALTH DRIVE, SUITE 9, FORT MYERS FL 33913
Daniel L. Hall director C/O HEALTHLYNKED CORP., 1035 COLLIER CENTER WAY SUITE 3, NAPLES FL 34110
Heather Monahan director 520 WEST AVE., #1704, MIAMI BEACH FL 33139
Paul Hobaica director 1265 CREEKSIDE PARKWAY, SUITE 302, NAPLES FL 34108
Robert P. Mino director 1072 LAKESHORE DR., JUPITER FL 33458
George O'leary director, officer: Chief Financial Officer C/O ISONICS CORPORATION, 5906 MCINTYRE STREET, GOLDEN CO 80403
Michael T Dent director, 10 percent owner, officer: Chief Executive Officer 12701 COMMONWEALTH DRIVE, SUITE 9, FORT MYERS FL 33913